National trends in the outpatient treatment of depression

JAMA

Volumn 287, Issue 2, 2002, Pages 203-209

  Olfson, Mark ^a   Marcus, Steven C ^b   Druss, Benjamin ^c   Elinson, Lynn ^d   Tanielian, Terri ^e   Pincus, Harold Alan ^e,f  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^e RAND CORPORATION   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; DRUG COST; DRUG TOLERABILITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MENTAL HEALTH CARE; OUTPATIENT CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 0037045439     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.2.203     Document Type: Article

References (42)

1. The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services
2. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
3. Cross-national epidemiology of major depression and bipolar disorder
4. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices
5. Social functioning in depression: A review
6. Health-related quality of life in primary care patients with mental disorders: Results from the PRIME-MD 1000 Study
7. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study
8. Evidence-based health policylessons from the Global Burden of Diesease Study
9. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression
10. Noradrenergic versus serotonergic antidepressants: Predictors of treatment response
11. Developments in interpersonal psychotherapy
12. Practice guideline for the treatment of patients with major depressive disorder
13. The role of psychotherapy in the treatment of depression: Review of two practice guidelines
14. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey
15. Use of services by persons with mental and addictive disorders: Findings from the National Institute of Mental Health Epidemiologic Catchment Area program
16. Safety and tolerability considerations: Tricyclic antidepressants vs selective serotonin reuptake inhibitors
17. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis
18. Antidepressant prescribing practices of outpatient psychiatrists
19. Drug advertisements and the medicalization of unipolar depression in women
20. Marketing "mind mechanics" decoding antidepressant advertisements
21. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study
22. Brief screens for mental disorders in primary care
23. Screening for depression in medical patients. Is the focus too narrow?
24. The NIMH Depression Awareness, Recognition, and Treatment Program: Structure, aims, and scientific basis
25. Treatment for depression following the 1996 National Depression Screening Day
26. Managed care and medication compliance: Implications for chronic depression
27. Quality of care and cost-containment in managed mental health: Policy, education, research, advocacy
28. Some economics of mental health "carveouts"
29. Tracking changes in behavioral health services: How have carve-outs changed care?
30. The prevalence and distribution of major depression in a National Community Sample: The National Comorbidity Survey
31. A comparison of nefazadone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression
32. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations